4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingPhase 32026-10-05NCT06982521
Middle Meningeal Artery Embolisation in Chronic Subdural HematomaChronic Disease, Craniocerebral Trauma, Disease Attributes, Hematoma, Hematoma, Subdural, Hematoma, Subdural, Chronic, Hemorrhage, Intracranial Hemorrhage, Traumatic, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, injury, nervous system disorder, nervous system injury, vascular disorderActive, not recruitingNot applicable2026-09-30NCT07751887
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to RuxolitinibHemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosisRecruitingPhase 32025-09-25NCT06479135
Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.Digestive System Diseases, Intestinal Failure, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, digestive system disorder, intestinal disorder, malabsorption syndrome, short bowel syndromeActive, not recruitingPhase 32025-07-02NCT05018286